Comparing Glycopyrrolate vs Combivent
Glycopyrrolate | Combivent |
|
---|
Glycopyrrolate | Combivent (albuterol / ipratropium) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Excessive Salivation, Anesthesia, Peptic Ulcer, COPD - Maintenance. glycopyrrolate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for COPD - Maintenance. Combivent may also be used for purposes not listed in this medication guide. |
Related suggestions COPD, Maintenance
|
|||||||
More about Glycopyrrolate | More about Combivent (albuterol / ipratropium) | ||||||||
Ratings & Reviews | |||||||||
Glycopyrrolate has an average rating of 8.7 out of 10 from a total of 18 ratings on Drugs.com. 87% of reviewers reported a positive effect, while 7% reported a negative effect. |
Combivent has an average rating of 8.0 out of 10 from a total of 23 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 10% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: glycopyrrolate side effects in more detail. |
See also: Combivent side effects in more detail. |
||||||||
Generic Availability | |||||||||
Lower cost generic |
Lower cost generic approved | ||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all glycopyrrolate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | |||||||||
|
|
||||||||
Brand Names | |||||||||
Cuvposa, Dartisla ODT, Glycate, Glyrx-PF, Lonhala Magnair | Other albuterol / ipratropium brands include: Combivent Respimat | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
N/A |
6.5 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 202 drugs are known to interact with glycopyrrolate:
|
A total of 484 drugs are known to interact with Combivent:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
August 11, 1961 |
October 24, 1996 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.